Covered recipient · General Payments record
ELIZABETH SCHULMAN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2024
$8,923.23
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $576.68 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $209.26 | 14 |
| Lilly USA, LLC | $184.41 | 12 |
| UCB, Inc. | $114.01 | 6 |
| Janssen Biotech, Inc. | $36.34 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $32.66 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.58 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042454 | CMS |
| ABBVIE INC. | $12.37 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042456 | CMS |
| ABBVIE INC. | $11.13 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042458 | CMS |
| ABBVIE INC. | $23.78 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042460 | CMS |
| ABBVIE INC. | $5.85 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042462 | CMS |
| ABBVIE INC. | $22.30 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042464 | CMS |
| ABBVIE INC. | $17.84 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042466 | CMS |
| ABBVIE INC. | $8.36 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042468 | CMS |
| ABBVIE INC. | $3.15 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042470 | CMS |
| ABBVIE INC. | $5.97 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042472 | CMS |
| ABBVIE INC. | $22.06 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042474 | CMS |
| ABBVIE INC. | $29.01 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042476 | CMS |
| ABBVIE INC. | $15.61 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042478 | CMS |
| ABBVIE INC. | $5.25 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106042480 | CMS |
| Janssen Biotech, Inc. | $18.78 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078447805 | CMS |
| Janssen Biotech, Inc. | $17.56 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078440901 | CMS |
| Lilly USA, LLC | $21.07 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136154934 | CMS |
| Lilly USA, LLC | $10.69 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136164350 | CMS |
| Lilly USA, LLC | $27.41 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136172430 | CMS |
| Lilly USA, LLC | $11.64 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136164352 | CMS |
| Lilly USA, LLC | $26.70 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136164354 | CMS |
| Lilly USA, LLC | $25.76 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134968975 | CMS |
| Lilly USA, LLC | $12.09 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136164356 | CMS |
| Lilly USA, LLC | $0.44 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134968977 | CMS |
| Lilly USA, LLC | $1.37 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134969631 | CMS |
| Lilly USA, LLC | $21.05 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136154936 | CMS |
| Lilly USA, LLC | $1.34 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136172432 | CMS |
| Lilly USA, LLC | $24.85 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136171762 | CMS |
| Novartis Pharmaceuticals Corporation | $16.33 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087167377 | CMS |
| Novartis Pharmaceuticals Corporation | $16.33 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087167379 | CMS |
| UCB, Inc. | $20.98 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143067589 | CMS |
| UCB, Inc. | $16.07 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143067591 | CMS |
| UCB, Inc. | $18.80 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143067593 | CMS |
| UCB, Inc. | $19.30 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143067595 | CMS |
| UCB, Inc. | $20.56 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143067597 | CMS |
| UCB, Inc. | $18.30 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143067599 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.